# Aprepitant

## EMEND 125mg

#### 一般可用

| 藥品代碼       | OEM125                                                                                                                                                                                                                                                         |
|:---------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Prevention of acute & delayed nausea & vomiting associated with initial & repeat courses of highly & moderately emetogenic cancer chemotherapy.                                                                                                                |
| 用法用量       | Given as part of a 3-day regimen that includes a corticosteroid and a 5-HT3 antagonist. Recommended dose: 125 mg orally 1 hour prior to chemotherapy (day 1) and 80 mg once daily in the morning on day 2 and day 3.                                           |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                   |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                   |
| 禁忌           | Concurrent administration with pimozide， terfenadine， astemizole， or cisapride.                                                                                                                                                                             |
| 副作用         | Hiccups， asthenia/fatigue， ALT increased， constipation， headache， anorexia. Central nervous system: Fatigue (?18%) Gastrointestinal: Nausea (6% to 13%)， constipation (9% to 10%) Neuromuscular & skeletal: Weakness (?18%) Miscellaneous: Hiccups (11%) |
| 孕期用藥建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                         |
| 哺乳期用藥建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                           |

